Department of Dermatology

Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment. (2022) Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L, Gesierich A, et al. Journal article Real-world data on the effectiveness, safety and drug survival of dupilumab: an analysis from the TREATgermany registry (2022) Stoelzl D, Sander N, Heratizadeh A, Haufe E, Harder I, Abraham S, Heinrich L, et al. Journal article Inhibition of Melanoma Cell-Intrinsic Tim-3 Stimulates MAPK-Dependent Tumorigenesis. (2022) Schatton T, Itoh Y, Martins C, Rasbach E, Singh P, Silva M, Mucciarone K, et al. Journal article Patch testing shellac in consecutive patients—Data of the Information Network of Departments of Dermatology (IVDK) 2021 (2022) Schubert S, Worm M, Dickel H, Wagner N, Brans R, Schroder-Kraft C, Bauer A, et al. Journal article Bin-based visualization of cytokine-co-expression patterns of IL-10-producing CD4 T cell subsets (2022) Mohr E, Hinnenthal T, Gryzik S, Hoang Y, Lischke T, Retzlaff J, Mekonnen A, et al. Journal article Lokaltherapeutisches Vorgehen bei Blasen der Haut: Ein Positionspapier der Initiative Chronische Wunden (ICW) e. V. (2022) Dissemond J, Bueltemann A, Gerber V, Motzkus M, Münter C, Erfurt-Berge C Journal article, Review article A Mixed Methods Assessment of the Management Role of Physicians (2022) Rechtien L, Gradel M, Fischer MR, Graupe T, Dimitriadis K Journal article Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study. (2022) Simon D, Tascilar K, Fagni F, Kleyer A, Krönke G, Meder C, Dietrich P, et al. Journal article Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study (2022) Dikmen HO, Yilmaz K, Benoit S, Bernard P, Drenovska K, Gerdes S, Glaeser R, et al. Journal article Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma. (2022) Schuler M, Zimmer L, Kim KB, Sosman JA, Ascierto PA, Postow MA, De Vos FY, et al. Journal article